CorneaGen Showcases 2023 Company Milestones and Momentum

March 7, 2024

CorneaGen Showcases 2023 Company Milestones and Momentum

Sight restoring grafts, service expansion, and surgeon partnerships make big industry impact

Seattle, WA – March. 6, 2024 – Seattle-based CorneaGen is proud to share several milestone successes from the past year, as momentum in 2024 starts off strong.  From total sight-restoring grafts to global services for surgeons, surgery centers and industry partners, CorneaGen is delivering on its mission to provide high quality tissue, service, and innovation to treat and care for every person impacted by corneal disease.

“CorneaGen is coming off a very successful 2023, which sets the organization up for what we believe will be an even stronger 2024,” said Tom Frinzi, CorneaGen Board Chair. “As a market leader we remain focused on areas like innovation and expanded eye recovery, enabling our stellar team to deliver on our commitment, providing the life-changing gift of sight.”

In 2023, CorneaGen provided more than 32,500 sight-restoring grafts, a record amount of tissue provided for transplant, impacting a record number of lives. CorneaGen now has nine strategically located offices/laboratories and partnerships with over 25 eye/organ/tissue banks to serve US corneal transplant needs, as well as Japan and nearly 50 additional countries.  From a financial perspective, CorneaGen experienced solid growth, which directly contributes to how it reinvests wholly into innovation and serving surgeon and patient needs.

“CorneaGen innovates with each new product, specifically benefitting patients and ultimately helping the entire ophthalmic sector,” said Bernie Iliakis, President & CEO. “Recent developments, including the EndoSerter-PL® for preloaded delivery of Nano-Thin™ or Ultra-Thin DSEK grafts and Corneal Tissue Addition for Keratoplasty (CTAK) to enhance treatment for keratoconic eyes, improves outcomes and surgical efficiency.”

The world’s leading provider of ocular tissue, CorneaGen’s mission is to provide the highest quality donor tissue and products, accomplishing this work through ophthalmic industry partnerships. In addition to product and tissue processing innovations, CorneaGen is an industry leader in patient advocacy. Through its efforts to simplify payor reimbursement and offer world class programs to advance surgeon education, CorneaGen helps tens of thousands of patients every year.

About CorneaGen
CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices, advocacy for patient access and simplified payor reimbursement policies, CorneaGen is advancing the next generation of cornea care.  As the world’s leading provider of ocular tissue, CorneaGen has multiple locations and local partnerships throughout the U.S. to deliver the life-changing gift of sight to tens of thousands of people each year. Read more at https://corneagen.com/.

Media contacts

Jared Young, CorneaGen VP Sales and Marketing

jared.young@corneagen.com

619-518-0734

Julie Fogerson, Fearey Group

jfogerson@feareygroup.com

425-503-3154